Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex
- 31 December 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (1), 48-59
- https://doi.org/10.1158/1078-0432.ccr-08-1805
Abstract
Purpose: Secretory clusterin (sCLU)/apolipoprotein J is an extracellular chaperone that has been functionally implicated in DNA repair, cell cycle regulation, apoptotic cell death, and tumorigenesis. It exerts a prosurvival function against most therapeutic treatments for cancer and is currently an antisense target in clinical trials for tumor therapy. However, the molecular mechanisms underlying its function remained largely unknown. Experimental Design: The molecular effects of small interfering RNA-mediated sCLU depletion in nonstressed human cancer cells were examined by focusing entirely on the endogenously expressed sCLU protein molecules and combining molecular, biochemical, and microscopic approaches. Results: We report here that sCLU depletion in nonstressed human cancer cells signals stress that induces p53-dependent growth retardation and high rates of endogenous apoptosis. We discovered that increased apoptosis in sCLU-depleted cells correlates to altered ratios of proapoptotic to antiapoptotic Bcl-2 protein family members, is amplified by p53, and is executed by mitochondrial dysfunction. sCLU depletion-related stress signals originate from several sites, because sCLU is an integral component of not only the secretory pathway but also the nucleocytosolic continuum and mitochondria. In the cytoplasm, sCLU depletion disrupts the Ku70-Bax complex and triggers Bax activation and relocation to mitochondria. We show that sCLU binds and thereby stabilizes the Ku70-Bax protein complex serving as a cytosol retention factor for Bax. Conclusions: We suggest that elevated sCLU levels may enhance tumorigenesis by interfering with Bax proapoptotic activities and contribute to one of the major characteristics of cancer cells, that is, resistance to apoptosis.Keywords
Other Versions
This publication has 40 references indexed in Scilit:
- Cancer Proliferation Gene Discovery Through Functional GenomicsScience, 2008
- The BCL-2 protein family: opposing activities that mediate cell deathNature Reviews Molecular Cell Biology, 2008
- Clusterin mediates TRAIL resistance in prostate tumor cellsMolecular Cancer Therapeutics, 2007
- Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseasesFree Radical Research, 2006
- Clusterin interacts with SCLIP (SCG10-like protein) and promotes neurite outgrowth of PC12 cellsExperimental Cell Research, 2005
- Clusterin inhibits apoptosis by interacting with activated BaxNature, 2005
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- Differential effects of clusterin/apolipoprotein J on cellular growth and survivalFree Radical Biology & Medicine, 2005
- Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cellsCell Death & Differentiation, 2000
- Interaction of Transforming Growth Factor β Receptors with Apolipoprotein J/ClusterinBiochemistry, 1996